Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Mesoblast Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

12 Apr 2014 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - MESOBLAST LTD (MSB-AU)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

17 Apr 2014 Thomson Reuters Stock Report 11 $25.00

Wright Investors Service Comprehensive Report for Mesoblast Ltd

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

13 Apr 2014 Wright Reports 40 $75.00

Mesoblast Limited - Response to ASX Price Query

08 Apr 2014 irasia.com 2 $23.00

Mesoblast Limited (MSB) - Financial Analysis Review

Mesoblast Limited (MSB) - Financial Analysis Review Summary Mesoblast Limited (Mesoblast) is a biotechnology service pr...

04 Apr 2014 GlobalData 34 $125.00

How Did High Flyers Turn into Soul Searchers? Maxim Analyst Jason Kolbert on the Recent Highs and Lows of Biotech Valuations

After soaring more than 56% last year, the NASDAQ Biotechnology Index is down almost 15% in the last month. In this interview...

03 Apr 2014 Streetwise Reports 4 $35.00

Mesoblast keeps rising: up 3.7% in 3 days

Mesoblast Limited (ASX:MSB), Australia's 2nd largest pharmaceuticals, biotechnology & life sciences company by market capital...

28 Mar 2014 News Bites Pty Limited 17 $5.00

Mesoblast Limited - Building out a Multi-Product Regenerative Medicine Company - - Keynote Presentation to Alliance for Regenerative Medicine Investor Day New York

27 Mar 2014 irasia.com 18 $207.00

Mesoblast inches higher, resistance at 12-day EMA

Mesoblast Limited (ASX:MSB), Australia's 2nd largest pharmaceuticals, biotechnology & life sciences company by market capital...

21 Mar 2014 News Bites Pty Limited 17 $5.00

Mesoblast inches higher, resistance at 12-day EMA

Mesoblast Limited (ASX:MSB), Australia's 2nd largest pharmaceuticals, biotechnology & life sciences company by market capital...

13 Mar 2014 News Bites Pty Limited 17 $5.00